Kielo Research is a brand that is dedicated to assisting clients in developing innovative therapies based on a patients first philosophy. They understand the importance of generating patient-centric evidence to support positive regulatory approval, access, and commercialization strategies. Their services include conducting patient preference studies and providing scientific support for patient-centered drug and medical device development.

In the pre-clinical development stage, Kielo Research helps clients understand the unmet medical needs in the target indication and measures patients' desirability of potential target product profiles. During clinical development, they support endpoint selection by determining which endpoints matter most to patients and develop evidence-generation strategies that involve meaningful patient input. When it comes to regulatory approval, Kielo Research quantifies the importance of clinical outcome assessments from the patient perspective and uses patient preference data to demonstrate a positive benefit-risk profile.

They also bring the patient voice to regulatory interactions. In terms of reimbursement, they measure process utility using patient preferences and utilize a custom value framework to showcase holistic treatment value. For commercialization purposes, Kielo Research communicates patient, caregiver, or clinician preferences regarding key treatment features.

They confirm the value of treatment with the 'patient approved' stamp and demonstrate patient preference over alternative treatments. With a focus on what truly matters to patients, Kielo Research offers a unique and comprehensive approach to helping clients develop innovative therapies. Whether it's pre-clinical development, clinical development, regulatory approval, reimbursement, or commercialization, Kielo Research is committed to generating patient-centric evidence that supports their clients' goals